Needle Market Size & Share 2025 - 2034

Needle Market Size

The global needle market size was valued at USD 8.5 billion in 2024. The market is expected to reach from USD 9.1 billion in 2025 to USD 16.4 billion in 2034, growing at a CAGR of 6.8% during the forecast period. Needles are medical devices used in hospitals for a variety of procedures across different medical specialties. The growth of the market is largely driven by the growing prevalence of chronic diseases such as cancer, cardiovascular, respiratory, and neurological disorders, among others.

For instance, in 2021, as per the data from the World Health Organization (WHO), non-communicable disease was responsible for 43 million deaths worldwide. Among these, cardiovascular disease was responsible for at least 19 million deaths followed by cancer with 10 million, chronic respiratory diseases with 4 million. In addition, the WHO reported that in 2022, more than one third of individuals experienced neurological disorders, making it one of the primary causes of illness and disability worldwide. Therefore, the growing incidence of these chronic illnesses has heightened the demand for multiple needle-based interventions for diagnostic and therapeutic purposes.
 

Moreover, the increasing number of surgeries worldwide is reshaping the surgical landscape, where needles play a significant role in guaranteeing effective treatment delivery. For example, as reported by WHO in 2023 over 300 million surgical procedures are performed each year around the world indicates the emphasis on utilizing high-quality, safe, and reliable needles, with patient safety being at the top.
 

The rise in surgeries worldwide is making it clear how vital precision and safety are in these methods. A needle is a mechanical device which is sharp and pointed and is designed in such a manner that it punctures the skin or the tissue of the human body.  It is commonly used along with a syringe or a catheter, playing a key role in diverse medical procedures.
 

Needle Market Trends

• There is an ongoing trend of incorporating needles into more sophisticated systems of drug delivery like prefilled syringes and auto-injectors. These systems improve patient compliance by improving convenience, safety, and accurate dosing. Innovations like these are especially important to patients who need regular injections, such as those suffering from chronic illnesses.
   
• Further, to reduce the risk of needlestick injuries among healthcare workers, there is increased use of safety-engineered needles. Such needles are configured to retract or shield after use, thereby reducing the likelihood of unwanted injury and infection. Stricter regulations on infection control and prevention are increasing the demand of such devices.
   
• Moreover, needle manufacturers are working on using materials that optimally combine comfort, durability, and patients’ need. Stainless steel has become preferred choice of the vendors owing to its hardness and lack of corrosion. Also, newer and better methods of applying coatings are being developed which are capable of minimizing pain during insertion to maximize patient comfort.
   
• The traditional insulin delivery technologies using needles are witnessing a shift due to the emergence of new market players like Novo Nordisk’s Ozempic (GLP-1 receptor agonists). Other market players, including Embecta, one of the foremost manufacturers of insulin pen needles, are reconsidering their strategic approaches in light of evolving treatment paradigms and market conditions.
   

Trump Administration Tariffs

• Tariffs from U.S. on imports of stainless steel, polymer resins, and precision micro-tubing from countries such as China have expanded the cost of raw materials utilized in needle production.
   
• High tariffs are expected to pose substantial impact especially on the manufacturers that source low-cost components such as needle cannulas, bevel-cutting machinery, and plastic hubs from countries in Asia Pacific.
   
• The trade limitations have disturbed supply chains, leading to production delays. Shifting vendors to meet FDA or CE regulatory guidelines, which has further slowed product registration and market accessibility.
   
• Supply disturbances are further expected to affect the critical programs such as vaccinations, insulin delivery, and needle-exchange initiatives particularly in underserved communities.
   
• To decrease reliance and keep up supply stability, companies are contributing to domestic automation and exploring alternative sourcing in India, Vietnam, Malaysia, and Eastern Europe.
   

Needle Market Analysis

Based on product, the market is segmented into pen needles, hypodermic needle, suture needle, blood collection needle, dental needle, acupuncture needle and other products. The market was estimated at USD 8.5 billion in 2024. The pen needle segment held revenue of USD 3 billion in 2024. The segment is poised for significant growth at a CAGR of 6.7% during the forecast period.
 

• The growth of this segment is highly accelerated due to their affordability, and extensive usage of pen needles. Owing to higher prevalence of diabetes, there is a higher demand for insulin delivery devices such as pen needles, which are an essential component for administering insulin via subcutaneous injections.
   
• For instance, according to National Diabetes Statistics Report of 2022, diabetes affected 37.3 million individuals, or 11.3% of the population in the U.S. In addition, according to Centers for Disease Control and Prevention (CDC), around 90-95% of diabetic patients have type 2 diabetes. Type 2 diabetes is a major factor contributing to the growing demand for pen needles.
   
• Additionally, pen needles are more user friendly, easy to handle, and designed for self-injection, specially in elderlies and visually impaired patients. As a result, their adoption is increasing specifically among geriatric age groups, contributing to the rising revenue growth in the segment.

Learn more about the key segments shaping this market

Download Free PDF

Based on the material type, needle market is segmented into glass needle, plastic needle, stainless steel needle/metallic needle and polyetheretherketone (PEEK) needles. The stainless steel/metallic needle segment dominated the market with a market share of 60.6% in 2024.
 

• The stainless-steel needle is well-known due to its properties that align with the stringent requirements of medical applications.
   
• Stainless steel is resistance to corrosion, which ensures the integrity of needle and optimum safety maintenance during medical procedures. Further, its compatibility with human tissues minimizes adverse responses, which makes it suitable for a wide array of medical uses.
   
• Also, stainless-steel is vital for keeping up cleanliness and preventing infections. This material offers suitability to effective sterilization, without the risk of corrosion, which is critical across healthcare settings.
   

Based on the usage type, needle market is segmented into disposable and reusable/sterilizable. The disposable segment dominated the market with a market share of 57.2% in 2024.
 

• Growing demand for safety, infection control, and convenience is driving the use of disposable needles, which is contributing to the revenue growth in the market.
   

Use of disposable needles helps various healthcare centers to significantly reduce the cost of sterilization and risk of hospital acquired infections (HAI).
 

• For instance, according to February 2025 study published in ScienceDirect Journal, annually, approximately 9.1 to 44.5 percent of healthcare workers worldwide experience at least one incident of self-inflicted needle stick or sharp injuries. Such injuries aid in the spread of certain blood borne infections such as Human Immunodeficiency Virus (HIV), Hepatitis B and C. Owing to increasing demand for reducing HAI incidence across healthcare settings, the demand for disposable needles is increasing.
   
• Moreover, to curb the incidence of blood borne infections such as HIV globally, The use of single-patient needles has been mandated across certain healthcare settings, as the devices otherwise pose the risk of being reused and subsequently get contaminated. Such policies are favourably supporting the rising demand for disposable needles.
   

Based on the application, needle market is segmented into, diagnostic and therapeutics. The therapeutics segment dominated the market with a market share of 57.6% in 2024. The therapeutic segment is further bifurcated into vaccination, drug delivery, aesthetic procedures, insulin administration, dental, surgical and other therapeutics applications.
 

• Leading share of the therapeutic segment can be attributed to the frequent medical application of needles, particularly in chronic disease management and for drug delivery.
   
• Conditions such as diabetes, rheumatoid arthritis, multiple sclerosis, cancer, and even a deficiency of growth hormone need medication which calls for an injection, on a regular basis over a long period of time. For example, patients who are undergoing treatment for diabetes have to depend significantly on injections for insulin administration, which increases the demand for needles.
   
• Additionally, the expansion of therapeutic needles has been supported by the global shift to injectable biologics and biosimilars for the treatment of autoimmune diseases, cancer, and cardiovascular disorders. The increase in the supply of these medicines, which are administered subcutaneously or intramuscularly, results in the need for high-grade, non-reusable, therapeutic needles.
   

Based on the end use, needle market is segmented into clinics, hospitals, diagnostic center, research laboratories, ambulatory surgical centers and home care settings. The hospitals segment held revenue of USD 3.1 billion in 2024, and the segment is poised for significant growth at a CAGR of 6.3% during the forecast period.
 

• The growth is largely driven by the high volume of surgical procedures performed in the hospitals. Hospitals serves as a primary consumer of needle, employing these in various surgeries, including abdominal, orthopedic, neurosurgical, and cosmetic procedures.
   
• Moreover, with a consistent flow of patients and a wide range of medical treatments, hospitals require a steady supply of needles to ensure precise and secure patient care. They serve as the primary consumer of needles, utilizing them for various applications such as drug administration, blood collection, and vaccinations, as well as more specialized uses in surgical procedures and constant disease management.

North America: The U.S. needle market is forecasted to reach USD 6.5 billion by 2034.
 

• The U.S. hold significant market share within the North American market, stimulated by ongoing advancements and an increasing emphasis on patient-focused healthcare options.
   
• Increasing incidence of chronic diseases such as diabetes and cancer in the U.S. also contributes to the market growth. According to the 2022 statistics from the American Diabetes Association, over 37 million people in the U.S., which is roughly 11% of the population, are suffering from diabetes while 8.4 million depend on insulin.
   
• Moreover, the leading companies and research institutes present in the U.S., plays a vital role in the development of tools used in surgeries such as needles.
   
• Furthermore, backing from regulatory authorities and the increasing investments in healthcare technology significantly contributes to the growth and development of the market in the country.
   

Europe: The needle market in the UK is projected to grow significantly from 2025 to 2034.
 

• The market in UK is experiencing significant growth, stimulated by the rising prevalence of chronic conditions such as cancer, diabetes, and cardiovascular disease among others. For instance, as per data from the Cancer Statistics for the UK, each year more than 385,000 cases of cancer were diagnosed in the country.
   
• The rising case of cancer is anticipated to stimulate the need for cancer associated surgeries such as tumor resection, and reconstructive surgeries among others. This in turn is driving the demand of precision needles across complex surgeries in UK.
   
• Additionally, the NHS encourages the adoption of home therapies which increases the use of pen needles, auto injectors and pre-filled syringes. UK patients are subsidized by the government for having access to modern systems for drug delivery that include therapeutic needles which are disposed of after use. 
   
• Furthermore, UK has become a major market for Biologics, with increasing consumption of injectable medications for autoimmune diseases, multiple sclerosis, and oncology. The Government of UK reports that the number of life sciences businesses based in the UK has been gradually increasing since the 2008/09 and reached 6,850 in 2021/22.
   

Asia Pacific: The needle market in the Japan is projected to grow significantly from 2025 to 2034.
 

• Japan has a significant elderly population, resulting in an increased need for age-related surgeries, including joint replacements, heart surgeries, and cancer care, impelling the increase in adoption of the needles in the surgeries. For example, in 2023 projections from the World Economic Forum revealed that 1 in 10 people in Japan are aged 80 years and above, which was about one-third of the total population.
   
• Moreover, Japan’s universal healthcare policy contains advanced reimbursement systems for chronic conditions, biologics, and self-injection devices. This increases the accessibility of hospitals, clinics, and pharmacies to patients which leads to high consumption of therapeutic and injectable needles.
   
• Moreover, government of Japan stringently regulates infection control protocols across hospitals and elderly care facilities, which enhances the use of safety and disposable needles, especially during immunizations, IV therapy, and other clinical procedures, driving the revenue growth in the market.
   

Middle East and Africa: The Saudi Arabia needle market is projected to grow significantly from 2025 to 2034.
 

• Saudi Arabia is modernizing and expanding its healthcare system, primarily focusing on primary care, digital health, and chronic disease management. Under Vision 2030, the Saudi Arabia is constructing new hospitals, clinics, and specialty centers which are significant consumers of needles for therapeutic and diagnostic purposes.
   
• Moreover, with an increasing prevalence of chronic diseases such as diabetes and cancer in the country, the demand for home-based care as well as self-injection treatments is increasing. This is contributing to an increasing consumption of pen needles, prefilled syringes, and safety engineered disposable needles in Saudi Arabia.
   

Needle Market Share

The market for needle is highly competitive, with both established players and new entrants consistently innovating and developing advanced products. In terms of revenue, the market is primarily dominated by leading firms such as Becton, Dickinson and Company; Terumo, B. Braun Medical, Cardinal Health, Smiths Medical (ICU Medical), and Stryker which collectively account for approximately 65% of the total market share. These companies are focusing on the development to enhance surgical precision and accuracy, enabling market players to strengthen their position in this growing sector.
 

Needle Market Companies

Some of the eminent market participants operating in the needle industry include:

• Albert David
• B. Braun Medical
• Becton, Dickinson and Company
• Cardinal Health
• Hamilton
• Merck
• Nipro
• Novo Nordisk
• Owen Mumford
• Schreiner Group
• Smiths Medical (ICU Medical)
• Stryker
• Terumo
• Thermo Fisher Scientific
   
• Becton, Dickinson and Company has presence across 190 countries globally, with a key focus towards serving hospitals, homecare, and pharmacies. The company offers advanced needles especially for diabetes care and vaccine delivery.
   
• Stryker has a strong focus on research and development activities, the company has invested approximately USD 1,388 million in financial year 2023.
   
• Thermo Fisher Scientific is one of the leading providers of laboratory instruments. The company offers a wide range of products and services, and it has presence over 50 countries worldwide. In 2024 the total revenue for the company was USD 42,879 million as per the company’s annual report.
   

Needle Industry News:

• In January 2025, Terumo announced the global launch of the terumo injection filter needle. The needle is indicated for intravitreal and hypodermic injections. As such, the Injection Filter Needle has a polyamide 5 micrometer mesh filter built into it which is designed for the purpose of blocking the injection of particles.
   
• In March 2024, Becton Dickinson announced the launch of new BD Vacutainer UltraTouch Push Button Blood Collection Set in India. The device facilitates the blood collection using thinner needles. The device helps to reduce pain and discomfort to the patient as well as the risk for needlestick injuries by 88%.
   
• In January 2023, Schreiner Group introduced its new Needle Trap with a first-opening indication feature. This new feature provides a clear visual signal when a needle is first opened, improving safety and preventing misuse. The Needle Trap is designed to enhance the user experience and streamline safety procedures in medical environments, particularly for healthcare professionals working with needles.
   
• In September 2022, Terumo India launched FineGlide, a sterile pen needle for patients who require regular insulin injections or other self-medication. FineGlide is a three-bevel ultra sharp needle with a high-grade silicone surface that is mild and more comfortable for patients. This launch strengthens Terumo’s commitment to improving diabetes care and expands its portfolio of advanced medical solutions in the Indian market.
   

The needle market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Pen needles
• Hypodermic needles
• Suture needles
• Blood collection needles
• Dental needles
• Acupuncture needles
• Other products

Market, By Material

• Glass needles
• Plastic needles
• Stainless steel/metallic needles
• Polyetheretherketone (PEEK) needles

Market, By Usage Type

• Disposable
• Reusable/sterilizable

Market, By Application

• Diagnostics
  • Blood collection
  • Biopsy
  • Sample transfer
  • Other diagnostics
• Therapeutics
  • Vaccination
  • Drug delivery
  • Aesthetic procedures
  • Insulin administration
  • Dental
  • Surgical
  • Other therapeutics

Market, By End Use

• Hospitals
• Clinics
• Diagnostic center
• Ambulatory surgical centers
• Home care setting
• Research laboratories

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada
• Europe 
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific 
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America 
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa 
  • South Africa
  • Saudi Arabia
  • UAE